Esperance Pharmaceuticals
-
2006
Company Description
Esperance Pharmaceuticals develops anticancer drugs that kill cancer cells without harming normal cells.
Esperance Pharmaceuticals is developing a new class of targeted anticancer drugs that selectively kill cancer cells without harming normal cells. Targeting occurs through binding to specific receptors on the cell's surface. The drugs kill even those cells known to be resistant to chemotherapeutic drugs.
-
Manufacturer:
Science and Engineering -
Formed:
2006 -
Founders:
Hector Alila -
Company Website:
-
Company E-mail:
-
Company Address:
Louisiana Emerging Technology Center, 340 East Parker Blvd.Baton Rouge, LAUnited States -
CEO:
- Hector Alila
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits